Ipsen：Ipsen – improving patient health outcomes
Ipsen – improving patient health outcomes
Company
https://www.ipsen.com
With a focus on transformative medicines in oncology, rare disease and neuroscience, our vision is to be a leading global mid-size biopharmaceutical company.
Ipsen
https://en.wikipedia.org
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on transformative medicines in three therapeutic areas: oncology, ...
Ipsen Global
https://www.ipsen.com
Ipsen is a global biopharmaceutical company focused on innovation and specialty care to improve the lives of patients around the world.
Ipsen pharmaceutical products
https://www.ipsen.com
Overview of pharmaceutical products created and manufactured by Ipsen in the fields of oncology, neuroscience and rare disease.
Ipsen S.A.(IPN.PA) 走勢圖
https://tw.stock.yahoo.com
Ipsen S.A.. IPN.PA. 加入自選股. 119.5EUR. 0.10(0.08%). 開盤中| 2024/05/10 17:09 台北時間 (股價延遲15 分鐘). 當日 5天 1個月 6個月 今年 1年 5年 全部.
Ipsen：職缺
https://tw.linkedin.com
Ipsen | 222568 位LinkedIn 關注者。We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three ...
法商益普生股份有限公司
https://news.gbimonthly.com
法商益普生(Ipsen)成立於1929年，長期投入癌症、神經醫學及罕見疾病的治療藥物研發，過去靠攝護腺癌、神經內分泌腫瘤用藥及肉毒桿菌素穩定發展，並於2005年在法國上市。
法商益普生股份有限公司台灣分公司
https://www.104.com.tw
Ipsen is a global specialty-driven biopharmaceutical group focused on innovation and Specialty Care. It develops and commercializes innovative medicines in ...
說明
https://zh.wikipedia.org